lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate

C157H200F3LiN28O19 — CID 164955446

About lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate

lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate (PubChem CID 164955446) has the molecular formula C157H200F3LiN28O19 and a molecular weight of 2847.44 g/mol. Its IUPAC name is lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate.

Molecular Properties

• Compound Name: lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate
• PubChem CID: 164955446
• Molecular Formula: C157H200F3LiN28O19
• Molecular Weight: 2847.44 g/mol
• Exact Mass: 2845.57
• IUPAC Name: lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate
• SMILES: C.CC1CCC(c2ccccc2)NC1.Cc1cc(NC(=O)C(=O)N2CC(C)CCC2c2ccccc2)cnc1N.Cc1cc(NC(=O)C(=O)N2CC(C)CCC2c2ccccc2)cnc1NC(=O)OC(C)(C)C.Cc1cc(NC(=O)C(=O)N2C[C@@H](C)CC[C@@H]2c2ccccc2)cnc1N.Cc1cc(NC(=O)C(=O)N2C[C@@H](C)CC[C@H]2c2ccccc2)cnc1N.Cc1cc(NC(=O)C(=O)N2C[C@H](C)CC[C@@H]2c2ccccc2)cnc1N.Cc1cc(NC(=O)C(=O)N2C[C@H](C)CC[C@H]2c2ccccc2)cnc1N.Cc1cc(NC(=O)C(=O)OCC(F)(F)F)cnc1NC(=O)OC(C)(C)C.[CH2-]CCC.[Li+]
• InChI: InChI=1S/C25H32N4O4.5C20H24N4O2.C15H18F3N3O5.C12H17N.C4H9.CH4.Li/c1-16-11-12-20(18-9-7-6-8-10-18)29(15-16)23(31)22(30)27-19-13-17(2)21(26-14-19)28-24(32)33-25(3,4)5;5*1-13-8-9-17(15-6-4-3-5-7-15)24(12-13)20(26)19(25)23-16-10-14(2)18(21)22-11-16;1-8-5-9(20-11(22)12(23)25-7-15(16,17)18)6-19-10(8)21-13(24)26-14(2,3)4;1-10-7-8-12(13-9-10)11-5-3-2-4-6-11;1-3-4-2;;/h6-10,13-14,16,20H,11-12,15H2,1-5H3,(H,27,30)(H,26,28,32);5*3-7,10-11,13,17H,8-9,12H2,1-2H3,(H2,21,22)(H,23,25);5-6H,7H2,1-4H3,(H,20,22)(H,19,21,24);2-6,10,12-13H,7-9H2,1H3;1,3-4H2,2H3;1H4;/q;;;;;;;;-1;;+1/t;2*13-,17+;2*13-,17-;;;;;;/m.1010....../s1
• InChIKey: MXJZUAAXRDTZRS-YIRRLLEASA-N
• XLogP: 24.02
• TPSA: 660.88 Ų
• H-Bond Donors: 15
• H-Bond Acceptors: 32
• Rotatable Bonds: 18
• Heavy Atoms: 208
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2847.44
LogP ≤ 5	24.02
H-Bond Donors ≤ 5	15
H-Bond Acceptors ≤ 10	32

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate?

The IUPAC name of lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate (CID 164955446) is lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate.

What is the SMILES notation for lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate?

The canonical SMILES for lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate is C.CC1CCC(c2ccccc2)NC1.Cc1cc(NC(=O)C(=O)N2CC(C)CCC2c2ccccc2)cnc1N.Cc1cc(NC(=O)C(=O)N2CC(C)CCC2c2ccccc2)cnc1NC(=O)OC(C)(C)C.Cc1cc(NC(=O)C(=O)N2C[C@@H](C)CC[C@@H]2c2ccccc2)cnc1N.Cc1cc(NC(=O)C(=O)N2C[C@@H](C)CC[C@H]2c2ccccc2)cnc1N.Cc1cc(NC(=O)C(=O)N2C[C@H](C)CC[C@@H]2c2ccccc2)cnc1N.Cc1cc(NC(=O)C(=O)N2C[C@H](C)CC[C@H]2c2ccccc2)cnc1N.Cc1cc(NC(=O)C(=O)OCC(F)(F)F)cnc1NC(=O)OC(C)(C)C.[CH2-]CCC.[Li+].

What is the InChIKey of lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate?

The InChIKey is MXJZUAAXRDTZRS-YIRRLLEASA-N. The full InChI is InChI=1S/C25H32N4O4.5C20H24N4O2.C15H18F3N3O5.C12H17N.C4H9.CH4.Li/c1-16-11-12-20(18-9-7-6-8-10-18)29(15-16)23(31)22(30)27-19-13-17(2)21(26-14-19)28-24(32)33-25(3,4)5;5*1-13-8-9-17(15-6-4-3-5-7-15)24(12-13)20(26)19(25)23-16-10-14(2)18(21)22-11-16;1-8-5-9(20-11(22)12(23)25-7-15(16,17)18)6-19-10(8)21-13(24)26-14(2,3)4;1-10-7-8-12(13-9-10)11-5-3-2-4-6-11;1-3-4-2;;/h6-10,13-14,16,20H,11-12,15H2,1-5H3,(H,27,30)(H,26,28,32);5*3-7,10-11,13,17H,8-9,12H2,1-2H3,(H2,21,22)(H,23,25);5-6H,7H2,1-4H3,(H,20,22)(H,19,21,24);2-6,10,12-13H,7-9H2,1H3;1,3-4H2,2H3;1H4;/q;;;;;;;;-1;;+1/t;2*13-,17+;2*13-,17-;;;;;;/m.1010....../s1.

What are the key properties of lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate?

lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate has a molecular weight of 2847.44 g/mol, XLogP of 24.02, 18 rotatable bonds, 15 hydrogen bond donors, and 32 hydrogen bond acceptors.

Where does this data come from?

All data for lithium;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5R)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-[(2S,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide;N-(6-amino-5-methyl-3-pyridinyl)-2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetamide;butane;tert-butyl N-[3-methyl-5-[[2-(5-methyl-2-phenylpiperidin-1-yl)-2-oxoacetyl]amino]-2-pyridinyl]carbamate;methane;5-methyl-2-phenylpiperidine;2,2,2-trifluoroethyl 2-[[5-methyl-6-[(2-methylpropan-2-yl)oxycarbonylamino]-3-pyridinyl]amino]-2-oxoacetate is sourced from PubChem (CID 164955446), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).